NCT00099775View on ClinicalTrials.gov

Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

September 30, 2005

Conditions
Candidiasis
Interventions
DRUG

Caspofungin

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00099775 - Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units | Biotech Hunter | Biotech Hunter